KKR agrees to invest in Precipart

• The Laubscher family will retain a significant minority ownership stake in Precipart
• KKR will invest in Precipart via its Health Care Strategic Growth Fund II
• KKR is a global investment firm based in New York

KKR has agreed to invest in Precipart, a contract manufacturer of precision components for the medical device and aerospace industries.

KKR plans to support Precipart in its growth organically and through M&A, according to a release.

Precipart, founded by the Laubscher family, has offices in Switzerland, London and New York.

The Laubscher family will retain a significant minority ownership stake in Precipart.

KKR will invest in Precipart via its Health Care Strategic Growth Fund II, a $4.0 billion fund.

“The medical device market is in need of sophisticated, scaled solution providers that can help customers navigate supply chain complexity, and we believe that Precipart is uniquely positioned to become a best-in-class partner to medical device OEMs,” said Anuv Ratan, director at KKR.

The transaction is subject to customary closing conditions.

KKR is a global investment firm that provides alternative asset management as well as capital markets and insurance services. It is based in New York.

No financial terms of the transaction were disclosed.